Product Information
ESCITALOPRAM 20 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0631 per EA under NDC 59746028110. Its NADAC has been published 86 times since May 15, 2024.
FDA first approved this application on Sep 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746028110
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202280FDA Approved
9/12/2012
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 20 MG TABLET has been published 86 times since May 15, 2024, and over the history we have for it it has declined 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0631 per EA |
|---|---|
| All-time high | $0.0802 (Jul 10, 2024) |
| All-time low | $0.0548 (Nov 20, 2024) |
| 52-week high | $0.0763 |
| 52-week low | $0.0631 |
| Median price | $0.0745 |
| Average price | $0.0719 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | May 15, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-17.3%
3Y
N/A
5Y
N/A
All
-5.3%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 20 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0631 per EA (NDC 59746028110), effective Dec 31, 2025.
How has the price of ESCITALOPRAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 20 MG TABLET has declined 5.3%. It has been tracked across 86 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 20 MG TABLET?
Since May 15, 2024, the NADAC for ESCITALOPRAM 20 MG TABLET has ranged from a low of $0.0548 (Nov 20, 2024) to a high of $0.0802 (Jul 10, 2024), with a median of $0.0745 per EA.
Are there cheaper alternatives to ESCITALOPRAM 20 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 20 MG TABLET, is $0.0628 per EA — about 1% below ESCITALOPRAM 20 MG TABLET.
Who manufactures ESCITALOPRAM 20 MG TABLET?
ESCITALOPRAM 20 MG TABLET (NDC 59746028110) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.